Tag: nasdaq:bgne

June 9, 2021

5 Small Biotech ETFs

Want to invest in small biotech ETFs? INN profiles five examples that life science investors may want to look into.
January 15, 2019

BeiGene Receives U.S. FDA Breakthrough Therapy Designation for Zanubrutinib

BeiGene (NASDAQ:BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the...
December 20, 2018

5 Top Biotech and Pharma Stocks on the TSX Year-to-Date

Which biotech and pharma stocks on the TSX have performed the best in 2018? Here's a look at the top...
August 9, 2018

BeiGene Announces Closing of Its HK$7.08 billion (US$903 million) Hong Kong Initial Public Offering and Global Offering

BeiGene (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of...